articleTop 10% cited
Pimonidazole: A Novel Hypoxia Marker for Complementary Study of Tumor Hypoxia and Cell Proliferation in Cervical Carcinoma
Gynecologic Oncology · 1998 · Vol. 71(2) · pp. 270–277
Mahesh A. Varia✉(University of North Carolina at Chapel Hill)Dennise P. Calkins-Adams(University of North Carolina at Chapel Hill)Lillian H. Rinker(University of North Carolina at Chapel Hill)Andrew S. Kennedy(University of North Carolina at Chapel Hill)Debra B. Novotny(University of North Carolina at Chapel Hill)Wesley C. Fowler(University of North Carolina at Chapel Hill)James A. Raleigh(University of North Carolina at Chapel Hill)
Cancer, Hypoxia, and MetabolismCancer Research and TreatmentsNanoplatforms for cancer theranosticsHypoxia (environmental)PathologyImmunostainingProliferating cell nuclear antigenTumor hypoxiaMedicineImmunohistochemistryMonoclonal antibodyCell growthCell
MeSH terms
Cell DivisionUterine Cervical NeoplasmsFemaleHumansImmunohistochemistryNitroimidazolesBiomarkersCell HypoxiaS PhaseProliferating Cell Nuclear Antigen
Citations
341
FWCI
3.53
field-weighted impact
References
33
Percentile
94%
vs. same field & year
Citations per year
Cited by
Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation
Diabetes · 2007 · 1,226 citations
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
JNCI Journal of the National Cancer Institute · 2001 · 2,637 citations
Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?
Frontiers in Oncology · 2020 · 446 citations
References
Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck
International Journal of Radiation Oncology*Biology*Physics · 1997 · 1,066 citations
Radiobiology for the Radiologist.
Annals of Internal Medicine · 1974 · 3,501 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
